Skip to main content
TipRanks
Go Ultimate75% OFF

William Reardon Insider Profile

4 Followers

William Reardon, Director at Madrigal Pharmaceuticals, holds 21.16K shares in Aceragen (Ticker: ACGN), holds 49.39K shares in Madrigal Pharmaceuticals (Ticker: MDGL), holds 0.00 shares in Tekla Healthcare Investors of Benef Interest (Ticker: HQH).

William Reardon's Trading History

ACGN
Aceragen
Jul 07, 2017―Uninformative Buy13.50K$8.04K
MDGL
Madrigal Pharmaceuticals
Jul 06, 2015DirectorUninformative Buy―$20.94M
HQL
Tekla Life Sciences Investors of Benef Interest
Jun 30, 2014DirectorInformative Buy11.42K$25.15K
HQH
Tekla Healthcare Investors of Benef Interest
―Director―$0.00

You May Also Like

William Reardon insider profile FAQ

What is the percentage of profitable transactions made by William Reardon?
The percentage of profitable transactions made by William Reardon is 50%.
What is the average return per transaction made by William Reardon?
The average return per transaction made by William Reardon is 7.80%.
What stocks does William Reardon hold?
William Reardon holds: MDGL, ACGN, HQH, HQL stocks.
What was William Reardon’s latest transaction?
William Reardon’s latest transaction was an Uninformative Buy of $13.50K.
What was William Reardon's most profitable transaction?
William Reardon’s most profitable transaction was an Informative Buy of ACGN stock on September 17, 2013. The return on the trade was 40.40%.
What is William Reardon's role in Madrigal Pharmaceuticals?
William Reardon's role in Madrigal Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.